{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":188,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":188,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"61c17db8e2f9","filters":{"venue":"Cancer Treatment Reviews"}},"results":[{"id":"W2560222145","doi":"10.1016/j.ctrv.2016.11.010","title":"Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":610,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"KWF Kankerbestrijding","keywords":"Medicine; Meta-analysis; PsycINFO; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Moderation; Psychological intervention; CINAHL; Body mass index; Clinical trial; MEDLINE; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1820672473880367,"gpt":0.4062354934846514,"spread":0.2241682460966147,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003283111,0.0005555512,0.008363948,0.0003244969,0.00001974947,0.0000069728,0.0001331133,0.000129515,0.00004423592],"category_scores_gemma":[0.0000323477,0.0002701036,0.000737374,0.0006218732,0.0001087457,0.0001105272,0.0000757064,0.0001099278,3.440546e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002187893,"about_ca_system_score_gemma":0.0003267019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002684062,"about_ca_topic_score_gemma":0.001996543,"domain_scores_codex":[0.9968436,0.0005996075,0.001126157,0.000775063,0.0004776521,0.000177882],"domain_scores_gemma":[0.9969327,0.0002108945,0.001486122,0.001062737,0.0001206305,0.0001869068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004256287,0.0008492347,0.01112397,0.02834858,0.03775433,5.997841e-7,0.0004128596,0.00000139024,2.481173e-7,0.000006139604,0.00002323695,0.9210538],"study_design_scores_gemma":[0.003511722,0.004063141,0.0168591,0.02193826,0.8761592,1.249829e-7,0.00003694612,0.000005727374,0.0000167127,0.000003945167,0.07686986,0.0005352946],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0490553,0.9446433,0.000002540082,0.000006970167,0.00005873463,0.002923474,0.003293709,0.000004739939,0.00001128151],"genre_scores_gemma":[0.02605237,0.9717793,0.00001368557,0.00002623006,0.00002955082,0.001163163,0.0008945504,0.00003097472,0.00001019047],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9205185,"threshold_uncertainty_score":0.9999751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1814699096","doi":"10.1016/j.ctrv.2004.08.002","title":"Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆☆☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Gefitinib; Medicine; Carboplatin; Paclitaxel; Lung cancer; Chemotherapy; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Cancer; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.01463295194877606,"gpt":0.3232133757697233,"spread":0.3085804238209472,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005482406,0.002399033,0.005096148,0.0007073262,0.0002161865,0.0002321655,0.0003141035,0.0008183024,0.0002068429],"category_scores_gemma":[0.00003022522,0.00159857,0.0003004381,0.0009604993,0.0002409414,0.0006861713,0.00007457774,0.00211704,0.000001978097],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006388156,"about_ca_system_score_gemma":0.004141427,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08312356,"about_ca_topic_score_gemma":0.1598435,"domain_scores_codex":[0.9920209,0.0004654111,0.002375298,0.002831019,0.000821693,0.001485663],"domain_scores_gemma":[0.9950166,0.0005798415,0.002388271,0.001196044,0.0003452953,0.0004738976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2660007,0.02234966,0.4287684,0.01669342,0.008818368,0.004553122,0.04191408,0.002387171,0.0076031,0.00001550605,0.01103746,0.189859],"study_design_scores_gemma":[0.8783428,0.01689292,0.02626301,0.02598039,0.005993706,0.00002574494,0.001369648,0.0009150907,0.00266406,0.00001785244,0.03764297,0.003891816],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8928692,0.04255258,0.00006519874,0.03167735,0.0007036021,0.02897067,0.002573028,0.0001004572,0.000487968],"genre_scores_gemma":[0.5401073,0.2716936,0.009373163,0.06727476,0.001954939,0.08897269,0.01299256,0.001474981,0.006156041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6123421,"threshold_uncertainty_score":0.9988747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089605820","doi":"10.1016/j.ctrv.2013.03.009","title":"Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":378,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; MAPK/ERK pathway; Medicine; Cancer research; Signal transduction; Kinase; Phosphorylation; RPTOR; Cell biology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03030317849100593,"gpt":0.2958380245302369,"spread":0.2655348460392309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002327857,0.0003919663,0.0005101069,0.00003134636,0.0001272112,0.00004342701,0.0002794367,0.0001116407,0.0002728167],"category_scores_gemma":[0.00001463061,0.0001892164,0.0002134548,0.0001676818,0.0001561964,0.00001086556,0.00003583321,0.00006815607,0.0000159405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002747732,"about_ca_system_score_gemma":0.0001612005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002555313,"about_ca_topic_score_gemma":0.0005103512,"domain_scores_codex":[0.9982103,0.0002629214,0.0004978176,0.0004980137,0.0001532683,0.000377656],"domain_scores_gemma":[0.9988745,0.00005541837,0.0002877823,0.0006332247,0.00007230466,0.00007678556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000167991,0.0009164265,0.05479304,0.0002383765,0.000562537,0.000009540749,0.003390442,0.0002539,0.2433631,0.00004941074,0.01634146,0.6799138],"study_design_scores_gemma":[0.002637892,0.001274589,0.01384039,0.0003650012,0.00037301,0.00002547974,0.0004079004,0.00009134928,0.04857901,0.0000509223,0.9318268,0.0005276406],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6243913,0.3713222,0.00002221813,0.001293886,0.0002717663,0.002170633,0.0001861189,0.000009767119,0.0003320931],"genre_scores_gemma":[0.6921396,0.3008852,0.0001423271,0.0005779095,0.0006936051,0.005051176,0.00006504371,0.00003830377,0.0004068915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9154854,"threshold_uncertainty_score":0.7716021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3107738233","doi":"10.1016/j.ctrv.2020.102134","title":"Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Meta-analysis; Immune system; Oncology; Bioinformatics; Immunology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05682420004956792,"gpt":0.3523567482553131,"spread":0.2955325482057452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001256953,0.0009544763,0.0215234,0.000251214,0.00007764575,0.00003770801,0.0001078829,0.0003296427,0.00007584404],"category_scores_gemma":[0.0002214731,0.0005346028,0.004428028,0.001152424,0.0000828157,0.00006627569,0.00007076346,0.000252964,0.000007166352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008470062,"about_ca_system_score_gemma":0.0001288726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003464723,"about_ca_topic_score_gemma":0.00002000733,"domain_scores_codex":[0.9944724,0.0005973565,0.003589979,0.000765883,0.0002941185,0.0002802647],"domain_scores_gemma":[0.9944415,0.0006182839,0.003969232,0.0006965678,0.00008028635,0.0001941061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001076596,0.00004050716,0.00002726441,0.5809199,0.2585909,0.00000525782,0.00006789526,9.72899e-9,0.000004356253,0.000001054051,0.00001381468,0.1603182],"study_design_scores_gemma":[0.001004984,0.0003437199,0.000119151,0.1465048,0.7265745,0.00001592959,0.000002393252,2.558701e-7,0.00001585988,0.000001683959,0.1251335,0.000283121],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003446081,0.9864193,9.901047e-7,0.0005348553,0.00004319999,0.01273333,0.0001589136,0.00002814452,0.00004685037],"genre_scores_gemma":[0.00003432703,0.9957755,0.0000465196,0.0001124093,0.00003977864,0.002722976,0.0002525842,0.00006003139,0.000955882],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4679837,"threshold_uncertainty_score":0.9997106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069700598","doi":"10.1016/j.ctrv.2008.03.011","title":"Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trials","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Colorectal cancer; Laparoscopic surgery; Hazard ratio; Cochrane Library; Surgery; Randomized controlled trial; Cancer; Laparoscopy; Colectomy; Meta-analysis; Rectum; Internal medicine; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1825859753002003,"gpt":0.467226585925209,"spread":0.2846406106250087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.003587339,0.001835297,0.08801366,0.000454095,0.00008162144,0.00001481815,0.0003435749,0.000481698,0.0008194543],"category_scores_gemma":[0.006594425,0.0009383067,0.02019049,0.0008880204,0.000219574,0.00006917593,0.0000485171,0.0002310916,0.00002260599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002695636,"about_ca_system_score_gemma":0.002608272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001488671,"about_ca_topic_score_gemma":0.00005510644,"domain_scores_codex":[0.9812574,0.003272371,0.01294174,0.001067366,0.0007877784,0.0006733923],"domain_scores_gemma":[0.9726775,0.01215377,0.01296292,0.001252049,0.000559766,0.0003940487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.003977013,0.0006676934,0.0005381492,0.8105921,0.01125234,0.00005060996,0.00001915508,5.400126e-8,9.576514e-7,0.0000016123,0.0005558448,0.1723445],"study_design_scores_gemma":[0.05234396,0.0008031218,0.0000150744,0.7718692,0.113056,0.00009458604,8.018258e-7,5.45253e-7,0.00003241968,4.962858e-7,0.06132883,0.0004549024],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007400236,0.8972182,0.00000595403,0.00005043046,0.0008874476,0.1003776,0.001201228,0.00004818263,0.000136944],"genre_scores_gemma":[0.00001286837,0.8500035,0.00005228525,0.0001007792,0.0002815496,0.1478514,0.0007292029,0.0001415057,0.0008269603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1718896,"threshold_uncertainty_score":0.9994392,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2300932108","doi":"10.1016/j.ctrv.2016.03.009","title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Lung cancer; Oncology; Radiation therapy; Internal medicine; Disease; Cancer; Population; Brain metastasis; Systematic review; Intensive care medicine; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.1160978657906826,"gpt":0.4254662371009093,"spread":0.3093683713102267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007765174,0.0006844985,0.00392314,0.0001459926,0.00005927352,0.0000124301,0.0001251372,0.0001268339,0.00009657124],"category_scores_gemma":[0.00008757858,0.0002603761,0.0008076993,0.000407466,0.00011158,0.0000334964,0.00003625164,0.0001280637,0.000002418843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001076035,"about_ca_system_score_gemma":0.0008172418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001951906,"about_ca_topic_score_gemma":0.0004403115,"domain_scores_codex":[0.9964983,0.0009653055,0.001360184,0.0005503579,0.0003055916,0.0003202585],"domain_scores_gemma":[0.9966177,0.0006434008,0.001628385,0.0008226952,0.0001051837,0.0001826369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003502834,0.0007048406,0.04135936,0.01221095,0.001671746,0.000001854352,0.00006207185,0.000002156462,1.12371e-7,0.00000973247,0.0004483239,0.9431786],"study_design_scores_gemma":[0.008035765,0.002497753,0.02654232,0.04960751,0.005528087,7.465551e-7,0.00001360224,0.000002294953,0.000005807772,0.000001659892,0.9073992,0.0003652895],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004554186,0.988544,0.000009626905,0.00006619444,0.00005337791,0.00550795,0.001001899,0.00000596135,0.0002567506],"genre_scores_gemma":[0.0005123185,0.9974222,0.00004940259,0.00002609932,0.00005368271,0.001316917,0.0002532321,0.00005917728,0.0003069688],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9428133,"threshold_uncertainty_score":0.9999849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123420272","doi":"10.1016/j.ctrv.2010.02.012","title":"Langerhans cell histiocytosis: Current concepts and treatments","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Malignancy; Histiocytosis; Immunotherapy; Salvage therapy; Disease; Immune system; Pathology; Immunology; Chemotherapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.11609083667682,"gpt":0.4510513757680648,"spread":0.3349605390912448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008716989,0.001211253,0.00449239,0.000187962,0.0001570655,0.00004554074,0.0001310271,0.0003769481,0.0005524492],"category_scores_gemma":[0.00001610816,0.0007242393,0.0011108,0.0002561799,0.0001497862,0.00006120457,0.00004403687,0.0003608087,0.0006718906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001570754,"about_ca_system_score_gemma":0.0007770034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001615812,"about_ca_topic_score_gemma":0.00006378617,"domain_scores_codex":[0.9971259,0.0001462571,0.0009600146,0.001026031,0.000228828,0.0005129651],"domain_scores_gemma":[0.9978806,0.00006627275,0.0006422746,0.0008752156,0.00004779532,0.0004878593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001038337,0.0009512514,0.0001390493,0.01447625,0.0004831229,0.00006212418,0.00009159033,7.199984e-9,3.948126e-7,0.00000911891,0.002336259,0.9814404],"study_design_scores_gemma":[0.002514287,0.0005075943,0.00001090352,0.01937831,0.01929349,0.00006894877,0.000004779381,6.145725e-7,0.000003306073,0.000004419783,0.957746,0.0004673163],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002829764,0.9879268,0.000003306259,0.00003295935,0.0007598001,0.005344622,0.00041311,0.00007740631,0.005413742],"genre_scores_gemma":[0.000004197698,0.9812019,0.0002474006,0.00005513519,0.0003618457,0.00612919,0.001057396,0.0001209015,0.01082199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9809731,"threshold_uncertainty_score":0.9995209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048922859","doi":"10.1016/j.ctrv.2014.12.010","title":"A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Frailty in Older Adults","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Ontario Council of University Libraries; Université de Montréal; Princess Margaret Cancer Centre; Jewish General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Gerontology; MEDLINE; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08762258422028803,"gpt":0.432860757652245,"spread":0.345238173431957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006307946,0.00225275,0.01991688,0.0004943594,0.0001028025,0.00004314724,0.0006597125,0.0004749422,0.002153229],"category_scores_gemma":[0.001221537,0.001063881,0.003541146,0.001388878,0.000070795,0.0001190957,0.0001730445,0.0002855552,0.0004455159],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007043435,"about_ca_system_score_gemma":0.001842989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001769877,"about_ca_topic_score_gemma":0.001267885,"domain_scores_codex":[0.9903146,0.0007320637,0.005632613,0.001611067,0.0008771966,0.0008324328],"domain_scores_gemma":[0.9913732,0.0009980117,0.003383036,0.003011714,0.0004111505,0.0008228187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000342544,0.0002304972,0.00002804686,0.5079699,0.0009814982,0.00001814748,0.0002419928,2.547194e-7,1.105086e-7,4.792098e-7,0.001628851,0.4888659],"study_design_scores_gemma":[0.001101136,0.0008182793,0.000008497622,0.5027311,0.02023878,0.00003859034,0.00001405219,7.239487e-7,0.000006820242,2.285912e-7,0.4746209,0.0004208781],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004365577,0.9611174,0.0000403333,0.0001766458,0.0006721166,0.03727694,0.0004525519,0.00009646434,0.0001238508],"genre_scores_gemma":[0.000002520227,0.9640773,0.0007875577,0.001160688,0.0004418616,0.02918291,0.0004496828,0.000246356,0.003651147],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4884451,"threshold_uncertainty_score":0.9991812,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988557714","doi":"10.1016/j.ctrv.2003.10.002","title":"Epidermal growth factor receptor: a promising target in solid tumours","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Monoclonal antibody; Tyrosine kinase; Cancer research; Cancer; Receptor tyrosine kinase; Signal transduction; Targeted therapy; EGFR inhibitors; Cetuximab; Blockade; Pharmacology; Receptor; Immunology; Antibody; Internal medicine; Biology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.2218575342477881,"gpt":0.4851877966864617,"spread":0.2633302624386736,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.000790698,0.001349577,0.007459244,0.0005395356,0.00009866651,0.00006892691,0.0003694707,0.000513508,0.003916231],"category_scores_gemma":[0.0002753176,0.0008836304,0.001610792,0.001137388,0.0001342632,0.0001192501,0.00007191265,0.0009851505,0.001062525],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009079195,"about_ca_system_score_gemma":0.004091311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004139974,"about_ca_topic_score_gemma":0.00008933489,"domain_scores_codex":[0.9932879,0.001267238,0.002140364,0.001423238,0.0005969771,0.001284344],"domain_scores_gemma":[0.9971007,0.0001809183,0.0007959245,0.001167856,0.0001266059,0.0006280295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002014348,0.000332472,0.0008249507,0.04519694,0.0002756271,0.0001690385,0.0001260003,1.348701e-7,0.000002645503,0.000009127849,0.01052856,0.9425144],"study_design_scores_gemma":[0.001075646,0.0003924149,0.00001747315,0.08023968,0.001015755,0.00009540491,0.000006099575,8.409235e-7,0.00003937689,0.000007022225,0.9165167,0.000593631],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001035357,0.9832271,0.000005201561,0.0002506722,0.0006892885,0.0109526,0.0002553012,0.00006665038,0.004542847],"genre_scores_gemma":[0.000001971731,0.982815,0.001100052,0.0002211349,0.0007580787,0.009762565,0.0003563224,0.0002449556,0.004739876],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9419207,"threshold_uncertainty_score":0.9999255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2563522215","doi":"10.1016/j.ctrv.2016.12.002","title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Number needed to harm; Angiogenesis; Internal medicine; Cardiology; Ischemia; Pharmacology; Relative risk; Number needed to treat; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1225346951841514,"gpt":0.3725759583253476,"spread":0.2500412631411962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0006990064,0.0008807963,0.02918796,0.000491369,0.00002276005,0.000006129045,0.000107014,0.0002702357,0.0001536753],"category_scores_gemma":[0.0000443204,0.0004278902,0.01836143,0.001283049,0.00008005488,0.00005066526,0.00001873868,0.00005140379,0.00000680311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001209113,"about_ca_system_score_gemma":0.0003052494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002504746,"about_ca_topic_score_gemma":0.00006421683,"domain_scores_codex":[0.9951466,0.0009503165,0.002554974,0.0007448648,0.0003433579,0.000259874],"domain_scores_gemma":[0.9965023,0.0001431131,0.001596964,0.001510057,0.0001048651,0.0001426632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000002975192,0.0001774267,0.000006884005,0.5586672,0.25703,0.00001005574,0.0000478808,1.722205e-7,0.00001016021,0.000002342346,0.000009474265,0.1840354],"study_design_scores_gemma":[0.000444508,0.0002213875,0.000001027192,0.1534786,0.6828313,0.00002106932,0.000002484101,6.020438e-8,0.0007942222,0.000001043669,0.1619996,0.0002046875],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001854074,0.9862478,0.00001291807,0.00005303357,0.00002646303,0.01317391,0.0003779632,0.00001219485,0.00007720423],"genre_scores_gemma":[0.00005532456,0.9909989,0.00008584824,0.00004939153,0.00004794317,0.008212022,0.00009319813,0.0000505621,0.0004067715],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4258013,"threshold_uncertainty_score":0.9998173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2080073879","doi":"10.1016/s0305-7372(02)00036-1","title":"Tamoxifen (‘Nolvadex’): a review","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Tamoxifen; Medicine; Tolerability; Breast cancer; Oncology; Aromatase; Internal medicine; Male breast cancer; Antiestrogen; Gynecology; Cancer; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.06805263237191005,"gpt":0.3792060415056269,"spread":0.3111534091337169,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001934179,0.0009865632,0.003142566,0.00006465182,0.0000875523,0.00002454904,0.0003923562,0.0005807584,0.0004016871],"category_scores_gemma":[0.00003336962,0.0005984643,0.002061567,0.0003026049,0.00006377022,0.000003281237,0.00009069889,0.0002448705,0.001099848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002530879,"about_ca_system_score_gemma":0.0002494486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001393928,"about_ca_topic_score_gemma":0.000004017961,"domain_scores_codex":[0.9970592,0.0004604013,0.0009422924,0.0009252593,0.0001385634,0.00047433],"domain_scores_gemma":[0.9978887,0.00001723435,0.0006586536,0.001176456,0.00003311456,0.0002257729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001699911,0.00008517675,8.689548e-7,0.0329431,0.0004770258,0.00001630006,0.000003237307,4.738793e-8,0.000004557422,0.000002508172,0.07413706,0.8923284],"study_design_scores_gemma":[0.000225894,0.0003132477,5.450205e-8,0.07652655,0.004006286,0.00009143343,1.984503e-7,1.598545e-7,0.00002078537,6.806125e-7,0.9182853,0.0005293893],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[4.426484e-7,0.991859,0.000003260636,0.00004827412,0.0003524751,0.004216569,0.0000860588,0.00002868355,0.003405222],"genre_scores_gemma":[4.707632e-8,0.9823803,0.00008012032,0.0003441549,0.0007106436,0.004711813,0.0009355661,0.0001176424,0.0107197],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.891799,"threshold_uncertainty_score":0.9996779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2795044371","doi":"10.1016/j.ctrv.2018.03.006","title":"Outlooks on Epstein-Barr virus associated gastric cancer","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Immunotherapy; Cancer; Epstein–Barr virus; Cancer research; Carcinogenesis; Immunology; Biomarker; Immune system; Immune checkpoint; Epstein–Barr virus infection; Virus; Cancer immunotherapy; Internal medicine; Biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.09538164567364876,"gpt":0.3900547197652027,"spread":0.2946730740915539,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.000364068,0.001617247,0.0067387,0.0003612173,0.0002383245,0.00006824161,0.0003420429,0.0008137396,0.00265575],"category_scores_gemma":[0.0001846795,0.001030733,0.002759887,0.001055854,0.0001369122,0.00006439214,0.00005147543,0.0005916039,0.001528663],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009810374,"about_ca_system_score_gemma":0.002278472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001810871,"about_ca_topic_score_gemma":0.0009575153,"domain_scores_codex":[0.9948725,0.0004784428,0.001629177,0.001400696,0.0005565354,0.001062632],"domain_scores_gemma":[0.9961858,0.0001364101,0.001794465,0.001208755,0.0001614966,0.0005130048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000484885,0.0005063447,0.00009929317,0.006322964,0.002022756,0.00004431556,0.00007732822,5.27491e-7,4.097396e-7,0.00001015558,0.0604474,0.93042],"study_design_scores_gemma":[0.002122123,0.001520121,0.00001647715,0.06884581,0.01272316,0.00000896792,0.000008350517,0.000001494845,0.000003902866,0.00001332709,0.9140028,0.0007334422],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001527773,0.9820894,0.000003571828,0.0001722871,0.00148689,0.005574851,0.0009312097,0.0001723564,0.009554145],"genre_scores_gemma":[0.000004294633,0.9722706,0.00004061446,0.001094311,0.001324172,0.00779297,0.0006794375,0.0002424729,0.01655111],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9296866,"threshold_uncertainty_score":0.9996575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2564183539","doi":"10.1016/j.ctrv.2016.11.013","title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Canada Research Chairs","funders":"","keywords":"Medicine; Radiation therapy; Immunotherapy; Stereotactic radiotherapy; Oncology; Toxicity; Targeted therapy; Medical physics; Radiosurgery; Intensive care medicine; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.109069694414428,"gpt":0.4184380013217582,"spread":0.3093683069073302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006337117,0.001275135,0.01283321,0.0001679258,0.00006761221,0.00002457208,0.0002031245,0.0002031827,0.001625051],"category_scores_gemma":[0.00006547761,0.0005041313,0.002004662,0.0003883398,0.0001347903,0.00007005098,0.00002436474,0.0001621437,0.00004224628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00128698,"about_ca_system_score_gemma":0.00070992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003569644,"about_ca_topic_score_gemma":0.000007366405,"domain_scores_codex":[0.9947596,0.001235747,0.002453449,0.0008060808,0.0003206719,0.0004244244],"domain_scores_gemma":[0.9955295,0.0004140999,0.002310218,0.001398423,0.00009390571,0.0002538128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000359196,0.0002982098,0.000003220345,0.4602312,0.003330108,0.00002355821,0.00002885342,7.838961e-10,0.00000141108,0.000006303227,0.0002935313,0.5357476],"study_design_scores_gemma":[0.001730837,0.001131706,8.213239e-7,0.4665616,0.007139894,0.0001577196,0.000001339353,1.124597e-7,0.000005612593,7.000259e-7,0.5230354,0.0002342724],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003267769,0.9761364,0.00002531343,0.0001699924,0.0002385789,0.02297508,0.0003695185,0.0000403851,0.00004143635],"genre_scores_gemma":[0.000001096061,0.9874338,0.0002162189,0.0006067093,0.0001437712,0.009896497,0.0001272877,0.0001305642,0.001444078],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5355134,"threshold_uncertainty_score":0.9999545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013822060","doi":"10.1016/j.ctrv.2011.11.006","title":"Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies","year":2011,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Biopsy; Breast cancer; Prospective cohort study; Cancer; Internal medicine; Estrogen receptor; Immunohistochemistry; Oncology; Progesterone receptor; Recurrent breast cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06003752994894729,"gpt":0.3643769508980925,"spread":0.3043394209491452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008215519,0.0003357322,0.000902883,0.0001486398,0.00004731915,0.000003008514,0.0001294896,0.00005643024,0.00007116605],"category_scores_gemma":[0.00002953555,0.0002443712,0.0002501479,0.0005183193,0.0001740485,0.00001551803,0.00008861922,0.0000362118,0.000002766061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003283579,"about_ca_system_score_gemma":0.0001032626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206373,"about_ca_topic_score_gemma":0.003198752,"domain_scores_codex":[0.998376,0.0001378508,0.000627448,0.0005130909,0.0001206625,0.0002249278],"domain_scores_gemma":[0.9986508,0.00001383366,0.0005436871,0.0003850839,0.0003239862,0.00008263809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004571774,0.002312209,0.9589729,0.0002368799,0.003431903,0.000001374357,0.002655906,0.00006080752,0.0005908715,0.000005612836,0.00007790434,0.03119648],"study_design_scores_gemma":[0.002856595,0.000180036,0.9801909,0.0004880744,0.003760476,1.404407e-7,0.0002545336,0.0000397791,0.0115598,0.000004231573,0.0004319446,0.0002334486],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7875298,0.2084168,0.00004950856,0.0001097295,0.0002129009,0.001830693,0.001796757,0.000009575677,0.00004417578],"genre_scores_gemma":[0.9009668,0.09709965,0.0003571542,0.00002225352,0.00003197559,0.001191312,0.0002307964,0.00001595637,0.00008412498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1134369,"threshold_uncertainty_score":0.9965166,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063000484","doi":"10.1016/j.ctrv.2005.04.007","title":"Radiotherapeutic management of brain metastases: A systematic review and meta-analysis","year":2005,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Brain metastasis; Randomized controlled trial; Oncology; Quality of life (healthcare); Dose fractionation; Cancer; Surgery; Metastasis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2063397414282274,"gpt":0.4564395740412884,"spread":0.2500998326130611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.001190321,0.001404928,0.03156465,0.00042372,0.0000602456,0.00002835381,0.0002208346,0.0001455037,0.002218362],"category_scores_gemma":[0.00001682345,0.0006794723,0.01159957,0.001463932,0.00009083248,0.00005704297,0.0000589767,0.0001501987,0.00006867488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007612049,"about_ca_system_score_gemma":0.0001553968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005711453,"about_ca_topic_score_gemma":0.00002150284,"domain_scores_codex":[0.9938381,0.001399351,0.002926023,0.001054309,0.0003704428,0.0004117746],"domain_scores_gemma":[0.9952283,0.0002174358,0.00215898,0.002041001,0.00006297177,0.0002913142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000001707008,0.0001962243,1.556006e-7,0.4542869,0.3513138,0.00003557706,0.000007630093,1.017686e-7,1.968023e-9,0.00004369603,0.0002398855,0.1938743],"study_design_scores_gemma":[0.0002773909,0.0001359809,8.937773e-8,0.08414658,0.4706268,0.00005415299,0.000002591898,3.047907e-7,7.170286e-8,6.551763e-7,0.4445643,0.0001911202],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.545634e-8,0.976833,0.00006510555,0.0005216537,0.00002347838,0.0215535,0.0007619569,0.00003065453,0.0002106712],"genre_scores_gemma":[1.09016e-7,0.9693485,0.003336497,0.0013412,0.00003393472,0.01917912,0.0004983619,0.00008980487,0.006172467],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4443244,"threshold_uncertainty_score":0.9998701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099688828","doi":"10.1016/j.ctrv.2007.06.004","title":"Treatments for metastatic melanoma: Synthesis of evidence from randomized trials","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Dacarbazine; Medicine; Jadad scale; Internal medicine; Randomized controlled trial; Meta-analysis; Melanoma; Oncology; Cochrane Library; Chemotherapy; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.5073897111193665,"gpt":0.5047787779505932,"spread":0.002610933168773255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003284802,0.001019035,0.02098105,0.000409595,0.00006682921,0.00002666837,0.0001898606,0.0002117608,0.001064494],"category_scores_gemma":[0.003023615,0.0004830832,0.00706452,0.0003572587,0.0001049836,0.00005265839,0.0000332477,0.0001082634,0.000120215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001470733,"about_ca_system_score_gemma":0.000454598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006861637,"about_ca_topic_score_gemma":0.00006947254,"domain_scores_codex":[0.9927427,0.001831244,0.003849078,0.0008585617,0.0003311975,0.0003872816],"domain_scores_gemma":[0.9841267,0.01134879,0.003184655,0.001003851,0.0001063311,0.0002296492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006338099,0.000371219,0.000001294434,0.02086316,0.01320044,0.00004696805,0.00004429351,1.239694e-7,0.000001763646,0.000008272772,0.001092917,0.9580315],"study_design_scores_gemma":[0.02466996,0.0003966449,2.61338e-7,0.05594948,0.1536475,0.00002963106,0.00000710192,0.000003116121,0.0000905895,0.00001355336,0.7649264,0.0002657957],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002999632,0.9685754,0.0008095191,0.00006336331,0.000685861,0.02878044,0.0005961995,0.00004993115,0.0004362941],"genre_scores_gemma":[0.000001629163,0.9596218,0.00469256,0.00004893939,0.0004061826,0.02917121,0.0002631717,0.00009592716,0.005698579],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9577656,"threshold_uncertainty_score":0.9998487,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971209307","doi":"10.1016/j.ctrv.2013.09.001","title":"HER2 testing: Current status and future directions","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"Genentech","keywords":"Medicine; Clinical Oncology; Human Epidermal Growth Factor Receptor 2; Medical physics; Breast cancer; Oncology; Intensive care medicine; Gynecology; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3352695861505894,"gpt":0.5178544713757319,"spread":0.1825848852251425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002305208,0.0009095986,0.003868061,0.0002450263,0.0001616483,0.00008780938,0.0001494071,0.0002669213,0.001495837],"category_scores_gemma":[0.00009705018,0.0005292612,0.0006896188,0.0008778781,0.0001246116,0.00007023862,0.00008368607,0.000670607,0.0006735604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003056373,"about_ca_system_score_gemma":0.001999307,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007592016,"about_ca_topic_score_gemma":0.00008299767,"domain_scores_codex":[0.99655,0.000362814,0.0009963785,0.0009705487,0.0003491306,0.0007710886],"domain_scores_gemma":[0.997474,0.0001753359,0.000459853,0.000996841,0.0001568235,0.0007371301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003025855,0.0001655356,0.000200314,0.04174985,0.0002416324,0.00001240266,0.00005283775,6.07715e-9,8.558041e-8,0.000008040383,0.0127047,0.9448616],"study_design_scores_gemma":[0.0004277085,0.0003684721,0.00005113014,0.04391725,0.003106599,0.000072692,0.000006395453,7.241657e-7,3.692741e-7,0.000003840234,0.9516737,0.0003711474],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002095886,0.9867876,7.317486e-7,0.000226004,0.001247604,0.008060629,0.0001598435,0.0001023029,0.003413228],"genre_scores_gemma":[3.002047e-8,0.9774729,0.0005003219,0.00004787401,0.003389194,0.01458685,0.0002144587,0.0001293219,0.003659062],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9444904,"threshold_uncertainty_score":0.9997159,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005542697","doi":"10.1016/j.ctrv.2008.01.002","title":"Cancer in pregnancy: Gaps, challenges and solutions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer; Pregnancy; Intensive care medicine; Oncology; Obstetrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2552469059883008,"gpt":0.4302623060746265,"spread":0.1750154000863257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006585473,0.0007581405,0.004084553,0.0002274547,0.00008059469,0.00001143754,0.00009644202,0.000292479,0.0003149602],"category_scores_gemma":[0.00001263728,0.0004725166,0.0007323977,0.0002712445,0.0001067787,0.00006437713,0.00004591874,0.000291406,0.00004475707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00203224,"about_ca_system_score_gemma":0.0009644513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001374434,"about_ca_topic_score_gemma":0.003762298,"domain_scores_codex":[0.9975609,0.0001395875,0.0008599494,0.0007891026,0.0001525938,0.0004978722],"domain_scores_gemma":[0.9986738,0.00005258401,0.000404861,0.0006041718,0.00002846483,0.0002361027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005277624,0.0001449714,0.00009661787,0.0183439,0.0002565028,0.00005878264,0.0002788368,1.017485e-7,5.540417e-8,0.00002374037,0.00102264,0.9797686],"study_design_scores_gemma":[0.0007101147,0.000152681,0.0002026002,0.1321317,0.001780075,0.00008205757,0.000006675052,4.773604e-7,2.044138e-7,0.000003776422,0.8646049,0.0003247108],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002264033,0.9934661,4.336362e-7,0.0002590129,0.0003618609,0.004105367,0.0002130312,0.00003849947,0.001553374],"genre_scores_gemma":[0.000001363833,0.9885504,0.00003214423,0.00004356356,0.0003923644,0.009104808,0.0000802117,0.00007822263,0.00171696],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9794438,"threshold_uncertainty_score":0.9997727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069702330","doi":"10.1016/s0305-7372(02)00044-0","title":"Cancer and thromboembolic disease: pathogenic mechanisms","year":2002,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Angiogenesis; Coagulation; Cancer; Tissue factor; Metastasis; Thrombosis; Cancer research; Immunology; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1001779872822767,"gpt":0.3818691053865992,"spread":0.2816911181043226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001645156,0.001202387,0.006788185,0.0002169727,0.0001645709,0.00006675444,0.0001948867,0.0002430317,0.002696415],"category_scores_gemma":[0.00001656439,0.0007488207,0.001461728,0.0003905145,0.00008336006,0.0000761148,0.000119297,0.0002286525,0.0004205516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001275645,"about_ca_system_score_gemma":0.0003955198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002295276,"about_ca_topic_score_gemma":0.00006865682,"domain_scores_codex":[0.9966003,0.0001770961,0.001062261,0.001203486,0.0003098646,0.0006469365],"domain_scores_gemma":[0.9974923,0.00004678384,0.0006318855,0.001121003,0.00004282463,0.0006652631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003124878,0.000531763,0.00001767578,0.03390139,0.001296924,0.0000913588,0.00005087286,1.189019e-7,3.892073e-7,0.0003734088,0.01001242,0.9537206],"study_design_scores_gemma":[0.0006394805,0.0002274024,0.0001552167,0.04551136,0.02918235,0.00001989678,0.000003697965,0.000002433748,5.158029e-7,0.00004444978,0.9236397,0.0005735651],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006091704,0.9896809,0.000009676949,0.0002704874,0.0005901058,0.007875041,0.0003312794,0.0001012253,0.001135196],"genre_scores_gemma":[0.000001862475,0.9771517,0.0001965105,0.0006342644,0.0006502772,0.01679847,0.0002480797,0.0001695293,0.004149336],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.953147,"threshold_uncertainty_score":0.9994963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083788852","doi":"10.1016/j.ctrv.2012.05.008","title":"Optimal management of elderly patients with glioblastoma","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Temozolomide; Cohort; Radiation therapy; Randomized controlled trial; Population; Oncology; Internal medicine; Adjuvant therapy; Glioblastoma; Cancer; Adjuvant; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.05812854951909599,"gpt":0.3517011236841146,"spread":0.2935725741650186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008604104,0.0009276818,0.004177407,0.0001952982,0.00005001593,0.00001440657,0.0001391333,0.0001683537,0.0005306124],"category_scores_gemma":[0.000001404468,0.000467906,0.001100768,0.0004466737,0.00006280637,0.00006533528,0.00004725538,0.0001108549,0.000252129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001016297,"about_ca_system_score_gemma":0.0001382066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003637831,"about_ca_topic_score_gemma":0.00001103121,"domain_scores_codex":[0.9974788,0.0001026682,0.0009970602,0.0006003015,0.000347579,0.0004736313],"domain_scores_gemma":[0.9977524,0.00003364058,0.0008975682,0.0009469813,0.00008007849,0.0002893093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005651223,0.00233929,0.001273652,0.03526409,0.003160164,0.00006658182,0.00002323577,2.842605e-7,1.318349e-8,0.00002037734,0.0003945535,0.9574012],"study_design_scores_gemma":[0.002647434,0.002524418,0.0002980607,0.05834393,0.03239075,0.00001749085,0.000003479532,6.930486e-8,0.000004758353,2.063138e-7,0.9034559,0.0003135407],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003595462,0.9906723,0.000002426813,0.00001360527,0.000177738,0.007431985,0.0001584827,0.00003112766,0.001152797],"genre_scores_gemma":[0.00004498784,0.9906649,0.001405241,0.00001471784,0.0001282261,0.006703373,0.0003957252,0.00010105,0.0005417914],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9570877,"threshold_uncertainty_score":0.9997773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968104780","doi":"10.1016/j.ctrv.2010.01.004","title":"New developments in arc radiation therapy: A review","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":144,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Ontario Institute for Cancer Research; Vanderbilt University Medical Center; Varian Medical Systems","keywords":"Medicine; Radiation therapy; Arc (geometry); Medical physics; Radiation oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06225025517620766,"gpt":0.4100070239524212,"spread":0.3477567687762135,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002129997,0.0008614903,0.003414592,0.0001513734,0.00005013815,0.00003004493,0.0003601725,0.0001594105,0.001822994],"category_scores_gemma":[0.000004087816,0.0005611175,0.0008014329,0.0005230933,0.00002029757,0.0001331366,0.00002324537,0.0003852244,0.00007857977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008192136,"about_ca_system_score_gemma":0.0009804677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003134468,"about_ca_topic_score_gemma":0.00002317365,"domain_scores_codex":[0.9974076,0.0002347562,0.00117832,0.0006587093,0.000138424,0.0003822378],"domain_scores_gemma":[0.9981135,0.0000518966,0.0009458546,0.0007230036,0.00002018601,0.0001455808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001160875,0.00006695395,0.0001243174,0.003733045,0.0001350671,0.000001311546,0.00002444209,2.326654e-8,3.208158e-7,0.00007777991,0.003177882,0.9926577],"study_design_scores_gemma":[0.0003587109,0.00003771018,0.000003362896,0.05637263,0.0002891976,0.000001403456,1.949404e-7,7.70757e-8,0.000006779715,0.00004848413,0.9424264,0.0004550302],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[5.365176e-8,0.9903827,0.001116882,0.00003615503,0.000242611,0.006281903,0.00004668539,0.00005383242,0.001839143],"genre_scores_gemma":[1.431214e-8,0.9791653,0.009472138,0.0001685115,0.0005674107,0.008291724,0.000362135,0.0001014468,0.001871317],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9922026,"threshold_uncertainty_score":0.999684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992904267","doi":"10.1016/j.ctrv.2012.07.004","title":"Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Medicine; Photodynamic therapy; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.1774068708841302,"gpt":0.4395065235343096,"spread":0.2620996526501793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007384344,0.001059783,0.005576838,0.0003868301,0.0001112725,0.00001790125,0.000392185,0.0001552695,0.001058727],"category_scores_gemma":[0.00001630131,0.0006052048,0.001872342,0.000588625,0.0002097128,0.00006536557,0.0001051402,0.0002656304,0.00009311697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001670952,"about_ca_system_score_gemma":0.0006491398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003852454,"about_ca_topic_score_gemma":0.00004743705,"domain_scores_codex":[0.9959458,0.0004975931,0.00145449,0.0007950567,0.0005428973,0.0007642236],"domain_scores_gemma":[0.9975885,0.0002010651,0.0007710821,0.0009755035,0.0001070887,0.0003567678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000122112,0.001339956,0.00005019408,0.0137577,0.003360564,0.00000658669,0.000446165,1.128029e-7,0.0001158046,0.00005766891,0.002937459,0.9778057],"study_design_scores_gemma":[0.001778977,0.0008740395,0.00007543612,0.01688371,0.001582808,0.00005769349,0.0000519231,0.00000128859,0.00003166409,0.00001016692,0.9782199,0.0004324343],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001744257,0.984579,0.00001771963,0.0002384367,0.0002054183,0.01298715,0.0009222158,0.00004489641,0.0008306885],"genre_scores_gemma":[0.00003123706,0.9828891,0.0007108026,0.0003876567,0.000349035,0.01256182,0.001292001,0.0001268465,0.001651516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9773732,"threshold_uncertainty_score":0.9998544,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2769738013","doi":"10.1016/j.ctrv.2017.11.005","title":"Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"KWF Kankerbestrijding","keywords":"Medicine; Guideline; Thyroid cancer; Harmonization; Family medicine; Cancer; Multidisciplinary approach; Thyroid nodules; Thyroid; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0294341776172911,"gpt":0.3322134058633581,"spread":0.302779228246067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004958872,0.0006189259,0.002364861,0.0001178137,0.0001456548,0.00005250156,0.0003304582,0.0001430549,0.00003389689],"category_scores_gemma":[0.000102058,0.0002846683,0.0002209326,0.0005031492,0.0002122854,0.0001254628,0.00008953101,0.0002739456,3.362825e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009335774,"about_ca_system_score_gemma":0.000847747,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06273293,"about_ca_topic_score_gemma":0.2805114,"domain_scores_codex":[0.9967787,0.000457202,0.00148218,0.000649848,0.0003568163,0.0002752647],"domain_scores_gemma":[0.9959559,0.0004159619,0.002448482,0.0007347655,0.0003701751,0.000074654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00007172379,0.0003492266,0.2371035,0.002107952,0.0008968821,0.000002751794,0.001407116,0.00007463478,0.000009516299,0.00001697167,0.0008794349,0.7570803],"study_design_scores_gemma":[0.008627221,0.0005327326,0.5049632,0.1316627,0.005095669,0.000009961576,0.0003118824,0.00008919268,0.0002863316,0.000006398911,0.3477959,0.0006187984],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02615142,0.9607528,0.000004323132,0.004385589,0.000560545,0.005745116,0.002377015,0.000008155098,0.00001504944],"genre_scores_gemma":[0.04033146,0.9530977,0.00004580549,0.000236722,0.00022729,0.005440581,0.0005418296,0.00005336091,0.00002523518],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7564614,"threshold_uncertainty_score":0.9999605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107249642","doi":"10.1016/j.ctrv.2004.03.004","title":"Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?","year":2004,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Aromatase; Adjuvant; Gold standard (test); Oncology; Internal medicine; Gynecology; Breast cancer; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02770559957191633,"gpt":0.3521868601886385,"spread":0.3244812606167222,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005610886,0.0005806857,0.001162864,0.0000626859,0.0001013505,0.00005818429,0.0004478222,0.0002442385,0.000008846438],"category_scores_gemma":[0.00004179925,0.0002471702,0.0007267799,0.000343887,0.00004781797,0.000002746356,0.00009362872,0.0002664409,0.00006702322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003995979,"about_ca_system_score_gemma":0.0004305239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001004377,"about_ca_topic_score_gemma":0.00006291756,"domain_scores_codex":[0.9977813,0.0004722917,0.0006180353,0.0005726981,0.0001550248,0.0004006174],"domain_scores_gemma":[0.9986849,0.00003965217,0.0002975437,0.0008664547,0.00001498023,0.00009641232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009454544,0.00004812832,0.000005279832,0.002075738,0.0001457428,0.00003553486,0.0001240109,0.000009188854,0.00002101737,0.000007106973,0.006949614,0.9905692],"study_design_scores_gemma":[0.0003102869,0.0003205971,0.000001351602,0.01498367,0.0006934907,0.00005986701,0.00001697777,2.034082e-7,0.0001363268,0.000002627301,0.983198,0.0002766118],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001299487,0.9949452,0.000004763313,0.0002275661,0.0002240361,0.003961144,0.0001284923,0.000009670849,0.0003691831],"genre_scores_gemma":[0.00004288835,0.9958386,0.00005806179,0.0002495624,0.000410711,0.002699848,0.0003420212,0.00005124522,0.0003070833],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9902925,"threshold_uncertainty_score":0.999998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070095096","doi":"10.1016/j.ctrv.2015.02.001","title":"Primary and secondary bone lymphomas","year":2015,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lymphoma; Malignancy; Pathological; Disease; Radiation therapy; Pathology; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.1147639642063472,"gpt":0.3917319352950804,"spread":0.2769679710887332,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002279734,0.001061796,0.006432081,0.0001715267,0.00008101548,0.00004804005,0.00009136725,0.0003209964,0.000473106],"category_scores_gemma":[0.00001348835,0.0005919054,0.001113721,0.0002618697,0.0000963135,0.0000783553,0.00008268956,0.0001335917,0.0004828186],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004827243,"about_ca_system_score_gemma":0.002528507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001505296,"about_ca_topic_score_gemma":0.00001974085,"domain_scores_codex":[0.9971569,0.0001897711,0.001060384,0.0009125745,0.0002520185,0.000428349],"domain_scores_gemma":[0.997817,0.00007752357,0.0005795474,0.0009029395,0.000059067,0.0005638772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001386903,0.0004940805,0.0001145915,0.02631069,0.0008493391,0.000328468,0.00003877819,3.577378e-9,4.166992e-8,0.00003418973,0.01843698,0.953379],"study_design_scores_gemma":[0.002966266,0.0005793899,0.00006600317,0.02998089,0.01298398,0.0007844765,0.00000273308,1.114746e-7,8.844755e-7,0.000008763896,0.9522024,0.0004240806],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007396355,0.9772394,2.638776e-7,0.00009360124,0.0003126222,0.004871309,0.0002418285,0.00006913987,0.01716438],"genre_scores_gemma":[3.93496e-7,0.9849184,0.0003229654,0.0003839189,0.0005190721,0.006536948,0.001044141,0.0000995705,0.006174631],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9529549,"threshold_uncertainty_score":0.9996532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125752165","doi":"10.1016/j.ctrv.2009.11.005","title":"SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer","year":2009,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Sanofi","keywords":"Medicine; Dasatinib; Prostate cancer; Proto-oncogene tyrosine-protein kinase Src; Bone metastasis; Osteoclast; Prostate; Bone resorption; Breast cancer; Cancer research; Metastasis; Oncology; Internal medicine; Tyrosine kinase; Cancer; Pathology; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.0557956574279283,"gpt":0.3779408648403471,"spread":0.3221452074124188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002827657,0.0009267473,0.004288096,0.0002597095,0.0001248247,0.00004123108,0.00003579592,0.0001257001,0.0001309999],"category_scores_gemma":[0.00002620245,0.0005696217,0.0003472756,0.0004663037,0.00009049442,0.0001322681,0.00003525917,0.0002785541,0.0000225916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00121692,"about_ca_system_score_gemma":0.0007309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002417777,"about_ca_topic_score_gemma":0.0004324711,"domain_scores_codex":[0.9967472,0.0002848229,0.001264644,0.0009269994,0.0001838825,0.00059246],"domain_scores_gemma":[0.9983895,0.00006100885,0.0006732662,0.000305545,0.00006186706,0.0005088386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006143818,0.000339268,0.001617996,0.03163701,0.0001793691,0.0008126415,0.00005381369,2.270278e-8,3.101929e-7,0.000008361055,0.0008911791,0.9643986],"study_design_scores_gemma":[0.002814014,0.000386534,0.000576654,0.06453519,0.004273114,0.0008349515,0.000006582065,6.63396e-7,0.000004249063,0.00001359726,0.9261666,0.0003878695],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003956688,0.9916434,2.519227e-7,0.0006611608,0.00009941973,0.006160809,0.0008660188,0.00003920478,0.000134036],"genre_scores_gemma":[0.00007473075,0.9925598,0.0003122766,0.0005323557,0.0001831512,0.005284103,0.0005588738,0.00006969806,0.0004250077],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9640107,"threshold_uncertainty_score":0.9996755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998765212","doi":"10.1016/j.ctrv.2008.05.001","title":"Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Waterloo","funders":"National Cancer Institute; Cancer Research UK; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Oncology; Disease; Value (mathematics); Bone disease; Internal medicine; Intensive care medicine; Osteoporosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1781497503111812,"gpt":0.4584829651475898,"spread":0.2803332148364086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003956101,0.0008755542,0.004883631,0.0002158651,0.0001476914,0.00002364805,0.00005638027,0.0001945563,0.00005497867],"category_scores_gemma":[0.000231778,0.0004813907,0.0007331511,0.0004961078,0.0001905404,0.0001040431,0.00004192157,0.0003931993,0.00003206515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007320431,"about_ca_system_score_gemma":0.001286716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003699892,"about_ca_topic_score_gemma":0.0001758665,"domain_scores_codex":[0.995805,0.0009026192,0.001634949,0.001013815,0.0001660021,0.0004775697],"domain_scores_gemma":[0.9971055,0.0007213822,0.0006140162,0.0006396518,0.00003694344,0.0008824986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009337508,0.0005893651,0.007036768,0.02229342,0.000442797,0.0004008131,0.00005601945,1.282785e-8,3.700821e-9,0.000004796814,0.0006050047,0.9684776],"study_design_scores_gemma":[0.001369657,0.0005265395,0.008382971,0.05995452,0.006074502,0.0005076553,0.000006959785,0.000003548744,1.236825e-8,0.000006883886,0.9228831,0.0002836532],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001725305,0.9896792,7.842992e-7,0.0007323469,0.0003624416,0.008798476,0.0001474395,0.00004149083,0.00006531059],"genre_scores_gemma":[0.00001222972,0.9917328,0.0003715921,0.0002079162,0.0003281272,0.006419153,0.0001770477,0.00006950924,0.0006815774],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9681939,"threshold_uncertainty_score":0.9997638,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041419946","doi":"10.1053/ctrv.2000.0204","title":"Locoregionally recurrent breast cancer: incidence, risk factors and survival","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Disease; Oncology; Retrospective cohort study; Internal medicine; Cancer; Risk factor","retraction":null,"screen_n_in":null,"score":{"opus":0.06059515640962599,"gpt":0.3620871464756759,"spread":0.3014919900660499,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0001778509,0.001524845,0.003347704,0.0001227394,0.0002726806,0.00005860646,0.0003599652,0.0004069737,0.0001737262],"category_scores_gemma":[0.00002612629,0.0009402774,0.001138443,0.0003777769,0.0002322,0.00001101239,0.0002296871,0.0002361583,0.0000342786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009048764,"about_ca_system_score_gemma":0.0006516178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002557501,"about_ca_topic_score_gemma":0.002936379,"domain_scores_codex":[0.9961959,0.0004691968,0.00094771,0.001498966,0.0002545935,0.0006336499],"domain_scores_gemma":[0.9975378,0.00007422062,0.001111529,0.0008861126,0.00009179648,0.0002985392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003558673,0.0001661056,0.01835146,0.002228971,0.001543362,0.000009457237,0.00003601658,6.99082e-7,4.028852e-7,0.000005746138,0.003084665,0.9745376],"study_design_scores_gemma":[0.0006240246,0.0001961725,0.002002597,0.007610315,0.004577841,0.00007777427,0.00001257403,2.575364e-7,0.000002889609,0.000005102188,0.9840848,0.000805579],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000227277,0.9932608,0.000009119759,0.00007512356,0.0008519451,0.002203293,0.003056667,0.00003253507,0.0002832693],"genre_scores_gemma":[0.00002755459,0.99222,0.00005307944,0.00004878452,0.001280967,0.004535077,0.001142125,0.0001259625,0.0005664157],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9810002,"threshold_uncertainty_score":0.99975,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2774652621","doi":"10.1016/j.ctrv.2017.12.006","title":"Staging and surgical approaches in gastric cancer: A systematic review","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hotel Dieu Hospital; Princess Margaret Cancer Centre; Ottawa Hospital; Grand River Hospital; Humber River Regional Hospital; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cancer; MEDLINE; Intensive care medicine; General surgery; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3244429439331436,"gpt":0.4413542188612157,"spread":0.1169112749280721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007707582,0.001022115,0.01171005,0.0003724637,0.0001048684,0.00008722866,0.0003077512,0.0001713682,0.0001802747],"category_scores_gemma":[0.00008445307,0.0005861119,0.001231615,0.0005067021,0.00008357386,0.0001086448,0.0001234665,0.0003274091,0.00004834227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001885144,"about_ca_system_score_gemma":0.0005287182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003977151,"about_ca_topic_score_gemma":0.000136238,"domain_scores_codex":[0.9959137,0.0003975988,0.00188908,0.0009406952,0.0003033533,0.0005555143],"domain_scores_gemma":[0.9967219,0.0001234368,0.001580405,0.001296663,0.00002695752,0.0002506132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000002778599,0.000042806,0.0002609055,0.5039334,0.0003160223,0.0001107226,0.00001229424,2.147426e-8,5.683294e-10,0.000006657557,0.0004514964,0.4948629],"study_design_scores_gemma":[0.0005481918,0.0000542899,0.00001018459,0.4704246,0.0137667,0.00007592775,0.000003127793,0.000001206319,7.046613e-9,5.543902e-7,0.5149069,0.000208237],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.200285e-7,0.9822517,0.000001402097,0.0003560346,0.0002072205,0.01562195,0.00004662834,0.00003915534,0.001475207],"genre_scores_gemma":[6.08858e-7,0.9750015,0.00006277331,0.0001427969,0.0002777955,0.01784392,0.0001156705,0.00007458789,0.006480382],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5144555,"threshold_uncertainty_score":0.999659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070849505","doi":"10.1053/ctrv.2000.0174","title":"Breast cancer risk following irradiation for Hodgkin’s disease","year":2000,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Disease; Radiation therapy; Cancer; Oncology; Internal medicine; Stage (stratigraphy)","retraction":null,"screen_n_in":null,"score":{"opus":0.04497273947181886,"gpt":0.3736856375486703,"spread":0.3287128980768515,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001527554,0.001219678,0.002599422,0.0001028477,0.0003194503,0.00005761989,0.0003167466,0.0003026412,0.0002054849],"category_scores_gemma":[0.0000206205,0.000851031,0.002850924,0.000228678,0.00006137546,0.00001148476,0.00005929666,0.0001167411,0.00006750321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001126792,"about_ca_system_score_gemma":0.0008744696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005268553,"about_ca_topic_score_gemma":0.0003741938,"domain_scores_codex":[0.9966618,0.000293057,0.0008789592,0.001366314,0.0001714346,0.0006284631],"domain_scores_gemma":[0.9978061,0.00005383083,0.0007974775,0.00098811,0.00005300263,0.000301523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009014762,0.0001659376,0.000504795,0.003422694,0.002083508,0.000004660819,0.00002258663,0.000006622748,3.912815e-7,0.00000226163,0.006280131,0.9874163],"study_design_scores_gemma":[0.001130157,0.00009704792,0.000265112,0.006931974,0.01291783,0.00000981729,0.00000247936,0.000001285241,0.000002356249,0.000007821034,0.9778818,0.0007522396],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002287169,0.983192,0.0000259541,0.0001041773,0.0008371229,0.004723743,0.01093073,0.00003856114,0.0001248525],"genre_scores_gemma":[0.00001416421,0.9593732,0.0001625407,0.0001028079,0.002112292,0.03315426,0.003598701,0.0001765254,0.001305523],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.986664,"threshold_uncertainty_score":0.9993941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2400707955","doi":"10.1016/j.ctrv.2016.05.003","title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus","year":2016,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Dalhousie University; Foothills Medical Centre; McGill University Health Centre; University of Ottawa; University of Toronto; Western University; University of Calgary; St Joseph's Health Care; Princess Margaret Cancer Centre; CancerCare Manitoba; Health Sciences Centre; University Health Network; Ottawa Hospital; BC Cancer Agency; St. Boniface Hospital; Sunnybrook Health Science Centre; University of British Columbia","funders":"","keywords":"Medicine; Neuroendocrine tumors; Radionuclide therapy; Everolimus; Medical literature; Disease; Intensive care medicine; Internal medicine; Pathology; Medical physics","retraction":null,"screen_n_in":null,"score":{"opus":0.1868509196828394,"gpt":0.4382014244135304,"spread":0.251350504730691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001602986,0.0008950933,0.003557518,0.0004956397,0.00008465426,0.00003231418,0.0002820363,0.0000106771,0.0005051257],"category_scores_gemma":[0.0001779169,0.000528284,0.0006119509,0.0004313211,0.0002953399,0.0001022359,0.0000684169,0.000225543,0.00007409603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001274984,"about_ca_system_score_gemma":0.001548131,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009218032,"about_ca_topic_score_gemma":0.006360679,"domain_scores_codex":[0.9959536,0.0005326128,0.001210214,0.001056312,0.0003707032,0.000876616],"domain_scores_gemma":[0.9964632,0.0004198998,0.0006513253,0.001159119,0.0001156958,0.001190797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004581307,0.0001578798,0.001083568,0.05954666,0.0001457889,0.01407043,0.000001367261,1.470639e-7,6.700224e-7,0.00001740765,0.0009002532,0.92403],"study_design_scores_gemma":[0.000748596,0.001472103,0.00007531099,0.2562422,0.001654475,0.003302797,0.000002659757,7.961981e-7,0.00001700393,0.000002513313,0.7362447,0.0002367934],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001010687,0.9910585,0.000001018458,0.0008966068,0.00008487926,0.007257882,0.000315933,0.00004150579,0.0002426466],"genre_scores_gemma":[0.00002281421,0.9907088,0.001243689,0.00013525,0.0001497641,0.00668587,0.00006653627,0.0001056425,0.0008816927],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9237932,"threshold_uncertainty_score":0.9997169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043154728","doi":"10.1016/j.ctrv.2020.102084","title":"Impact of high tumor mutational burden in solid tumors and challenges for biomarker application","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Biomarker; Oncology; Cancer; Melanoma; Lung cancer; Clinical trial; Targeted therapy; Circulating tumor cell; Internal medicine; Computational biology; Cancer research; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.124820301203392,"gpt":0.4267512769085064,"spread":0.3019309757051145,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001891832,0.0004794024,0.003073281,0.0001679091,0.0000245825,0.00000856303,0.00008565154,0.0001162323,0.00007790166],"category_scores_gemma":[0.00002302903,0.0002923156,0.0009183709,0.0002706837,0.00007083163,0.00003765774,0.00001511028,0.000075374,0.000006353217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00110825,"about_ca_system_score_gemma":0.0007421249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006799557,"about_ca_topic_score_gemma":0.00006644658,"domain_scores_codex":[0.9980738,0.0000934128,0.0009866365,0.0005248877,0.0001158445,0.0002054038],"domain_scores_gemma":[0.9986991,0.0001118663,0.0007335934,0.0003044087,0.0000473153,0.0001036921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002691622,0.0001019323,0.00003545421,0.02460167,0.00077893,0.000008669552,0.00009947178,2.1365e-7,0.00001033917,0.0000116756,0.000121408,0.9739611],"study_design_scores_gemma":[0.002003182,0.000801892,0.0009651804,0.01797763,0.001527963,0.00006088335,0.00000891846,0.00001194558,0.000004301181,0.00001576547,0.9763997,0.0002225986],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009969719,0.9927808,0.00001312783,0.0003379677,0.00005596116,0.006276549,0.0003673085,0.0000137405,0.00005485024],"genre_scores_gemma":[0.0001489292,0.9917269,0.0002065595,0.00002848329,0.0002194385,0.007075988,0.0004902146,0.00005039865,0.0000530516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9762783,"threshold_uncertainty_score":0.9999529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021777913","doi":"10.1016/j.ctrv.2011.12.002","title":"Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials","year":2012,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Sunnybrook Health Science Centre; Health Sciences Centre; MacEwan University","funders":"Alberta Health Services","keywords":"Medicine; Sunitinib; Pazopanib; Bevacizumab; Oncology; Clinical trial; Sorafenib; Breast cancer; Internal medicine; Adverse effect; Randomized controlled trial; Chemotherapy; Cancer; Angiogenesis","retraction":null,"screen_n_in":null,"score":{"opus":0.10315423392928,"gpt":0.3966961620687006,"spread":0.2935419281394205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024148,0.001121173,0.01286591,0.0002074342,0.00005337939,0.0000192536,0.0005247052,0.0004755603,0.0003423117],"category_scores_gemma":[0.0001074541,0.000684555,0.005695864,0.0006028427,0.00006907328,0.00000946223,0.00008880011,0.00008831783,0.00003866152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005679441,"about_ca_system_score_gemma":0.0007910438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000295173,"about_ca_topic_score_gemma":0.00008166065,"domain_scores_codex":[0.9923657,0.001952518,0.003929651,0.0008682599,0.0002559637,0.0006279004],"domain_scores_gemma":[0.9947215,0.0001325728,0.003540783,0.00127162,0.0001396703,0.0001938657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001080379,0.0001272443,0.0001217686,0.6876527,0.001823209,0.000002407248,0.000006851561,7.939182e-7,0.00005817032,0.00000269041,0.0006189184,0.3095744],"study_design_scores_gemma":[0.0003485316,0.00004113007,0.000003455728,0.444518,0.01734582,0.00002498079,0.000001691109,2.189737e-7,0.00004714895,1.987586e-7,0.5372891,0.0003796603],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007613772,0.9892347,0.00001480249,0.00004387232,0.0004347721,0.008667758,0.001537661,0.00001052007,0.00004830976],"genre_scores_gemma":[0.00001789791,0.9825887,0.00004859849,0.0002317714,0.0008968466,0.01531132,0.0004973341,0.0001281037,0.0002794114],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5366702,"threshold_uncertainty_score":0.9995605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010059199","doi":"10.1016/j.ctrv.2013.01.002","title":"HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lapatinib; Pertuzumab; Trastuzumab; Oncology; Breast cancer; Internal medicine; Neoadjuvant therapy; Clinical trial; Targeted therapy; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.3064769407507671,"gpt":0.523487102194639,"spread":0.2170101614438719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004859213,0.001619462,0.03128399,0.0005753308,0.00005086873,0.00004197379,0.0006983014,0.0005008341,0.007248179],"category_scores_gemma":[0.0006024938,0.0008351121,0.00402048,0.001840111,0.0001467571,0.0001022863,0.00008129886,0.0006754259,0.0004744997],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00539908,"about_ca_system_score_gemma":0.004483171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004154501,"about_ca_topic_score_gemma":0.0001310594,"domain_scores_codex":[0.9843438,0.005112592,0.007375603,0.001247684,0.0009837135,0.0009366396],"domain_scores_gemma":[0.9916176,0.0007375827,0.004275792,0.002469724,0.0004063693,0.0004929754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00001767744,0.0002214845,0.00002131788,0.5058973,0.0008354816,0.00002681834,0.00003098197,3.832062e-8,9.240275e-7,0.00000188147,0.005243374,0.4877027],"study_design_scores_gemma":[0.0009291964,0.000255127,0.000003293094,0.5069978,0.005260452,0.00006885285,0.00000371872,5.756652e-7,0.000003295701,0.000001098507,0.48618,0.0002966801],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001197498,0.9419979,7.973655e-7,0.0007647689,0.0004518594,0.05551837,0.0008389103,0.00004919367,0.0003770357],"genre_scores_gemma":[2.663882e-7,0.9073204,0.00009175741,0.0005736791,0.0004757017,0.08930814,0.0002797023,0.0002037408,0.001746594],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.487406,"threshold_uncertainty_score":0.9996553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156954151","doi":"10.1016/j.ctrv.2014.02.007","title":"TCTP as therapeutic target in cancers","year":2014,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Cancer research; Extracellular; Cellular stress response; Reversion; Cell biology; Biology; Bioinformatics; Fight-or-flight response; Phenotype; Gene; Pathology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.0849936651446577,"gpt":0.413684904276676,"spread":0.3286912391320184,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004170566,0.001187349,0.006943388,0.000374183,0.00008086528,0.00004094953,0.0003007827,0.0004174902,0.001541235],"category_scores_gemma":[0.00005014038,0.0007509186,0.001884479,0.0006471243,0.0001378298,0.00006791177,0.00003058632,0.0004337748,0.0006826816],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005627145,"about_ca_system_score_gemma":0.003326153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002467526,"about_ca_topic_score_gemma":0.0004152942,"domain_scores_codex":[0.9958174,0.0006810057,0.001512697,0.0009719142,0.0002945391,0.0007224026],"domain_scores_gemma":[0.997373,0.0001904434,0.0007966846,0.001317236,0.00004675483,0.0002758608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001150568,0.0001437893,0.00007985452,0.01901844,0.0004269016,0.00007649194,0.0001120351,9.684497e-7,5.386017e-7,0.00001258108,0.003365745,0.9766476],"study_design_scores_gemma":[0.001359145,0.000626913,0.00002568164,0.05118907,0.003351987,0.0001829856,0.00001112549,0.000002569455,0.000003237872,0.000008747854,0.9426668,0.000571689],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007984778,0.9896833,0.000003844006,0.000208277,0.00071128,0.005196529,0.00003946468,0.00006129764,0.004087994],"genre_scores_gemma":[0.000002954233,0.9786296,0.0000671936,0.0007647274,0.001276372,0.00672554,0.0002376253,0.0001608911,0.01213508],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9760759,"threshold_uncertainty_score":0.9994942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766249538","doi":"10.1016/j.ctrv.2017.10.008","title":"Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis","year":2017,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Meta-analysis; Oncology; Internal medicine; Hazard ratio; Epidermal growth factor receptor; Triple-negative breast cancer; Cancer; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.3223656559171788,"gpt":0.5041202922561302,"spread":0.1817546363389514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001096211,0.001472753,0.03014074,0.0005874368,0.0001625536,0.0001574258,0.0004367081,0.0003733544,0.001829997],"category_scores_gemma":[0.0003520617,0.0007323931,0.00418005,0.0007199388,0.00017203,0.0002136742,0.000204211,0.0005747667,0.00007104022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001908827,"about_ca_system_score_gemma":0.0008059929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004465402,"about_ca_topic_score_gemma":0.0005112851,"domain_scores_codex":[0.9928052,0.001661237,0.002657318,0.001519583,0.0006371269,0.0007194834],"domain_scores_gemma":[0.9946604,0.0003957934,0.00211495,0.002054434,0.0001657656,0.0006086987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000008178262,0.0001071527,0.001497831,0.8070543,0.06959364,0.00003335764,0.00006668424,8.148913e-9,1.234281e-7,0.000002450114,0.0005209585,0.1211153],"study_design_scores_gemma":[0.0003575121,0.0000827144,0.0001996889,0.2475708,0.4791995,0.00004137371,0.000001459286,3.018574e-7,2.608583e-7,8.332034e-7,0.2721849,0.0003606983],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006651663,0.9782003,8.367237e-7,0.001366899,0.00006148267,0.01780637,0.002436432,0.00003124581,0.00008980637],"genre_scores_gemma":[0.000007292761,0.9647055,0.00008495149,0.0003774799,0.00008933402,0.03023605,0.0001059527,0.000111255,0.004282186],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5594836,"threshold_uncertainty_score":0.9998022,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2884829265","doi":"10.1016/j.ctrv.2018.07.012","title":"Systematic review and meta-analysis of distance-based physical activity interventions for cancer survivors (2013–2018): We still haven’t found what we’re looking for","year":2018,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cancer survivorship and care","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Athabasca University","funders":"Canada Research Chairs","keywords":"Medicine; Psychological intervention; Meta-analysis; Haven; Cancer; Systematic review; MEDLINE; Gerontology; Safe haven; Oncology; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.2767488603845295,"gpt":0.4641507615719709,"spread":0.1874019011874414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0009482316,0.001310756,0.0224029,0.0003789405,0.0001354223,0.0001039217,0.0003165513,0.0002487066,0.0003648334],"category_scores_gemma":[0.0001137104,0.0007635076,0.01778278,0.001036116,0.0001949692,0.000238126,0.00005353915,0.0001880479,0.000006151282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0016016,"about_ca_system_score_gemma":0.0005476021,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001402819,"about_ca_topic_score_gemma":0.04380618,"domain_scores_codex":[0.9949761,0.0007038388,0.0020903,0.001303508,0.0003876946,0.0005385669],"domain_scores_gemma":[0.993477,0.0009563508,0.003208232,0.001667854,0.0004099983,0.0002805695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00002786964,0.0003398344,0.000001490664,0.7168232,0.1023108,9.848621e-7,0.0001466128,5.736945e-7,4.62493e-8,0.00001285322,0.000592348,0.1797433],"study_design_scores_gemma":[0.0002260678,0.0002185202,1.665608e-7,0.2212095,0.4001255,6.297391e-7,0.00002183428,0.00001766026,0.00000114865,0.000004161137,0.377931,0.0002438417],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002253157,0.9685396,0.001631898,0.0008866012,0.0004795806,0.02379889,0.004615854,0.00003472605,0.00001062549],"genre_scores_gemma":[0.00001641057,0.9268029,0.000118151,0.000164035,0.0002022419,0.06978256,0.0006020005,0.0001253916,0.002186287],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4956138,"threshold_uncertainty_score":0.9999644,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025769302","doi":"10.1016/j.ctrv.2008.05.007","title":"The kisspeptin (KiSS-1)/GPR54 system in cancer biology","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Plant Reproductive Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Kisspeptin; Paracrine signalling; Autocrine signalling; KISS (TNC); Metastasis; Metastasis Suppressor Gene; Cancer; Cancer research; Mechanism (biology); Medicine; Biology; Cell biology; Receptor; Bioinformatics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08958089845718112,"gpt":0.4000963147817178,"spread":0.3105154163245367,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003142789,0.0008913072,0.002551666,0.00009396123,0.0001737138,0.00001943677,0.0006246463,0.0006144226,0.00002542461],"category_scores_gemma":[0.00006805557,0.000468464,0.0008322598,0.0002792679,0.0002465821,0.000002854802,0.0001480782,0.000237216,0.0001282335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001050057,"about_ca_system_score_gemma":0.000814453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000589575,"about_ca_topic_score_gemma":0.001052205,"domain_scores_codex":[0.9958344,0.0009144222,0.001120569,0.0013813,0.00007797563,0.0006713058],"domain_scores_gemma":[0.9976491,0.00006611407,0.0008111357,0.001305121,0.00005545335,0.0001130881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001768546,0.00005647384,0.0002077972,0.001809024,0.0003436182,0.00001534739,0.000009758916,6.27577e-7,0.0001165183,0.00005118043,0.00436453,0.9930074],"study_design_scores_gemma":[0.0002692046,0.0002283738,0.00001212525,0.003818934,0.0003131974,0.0001535169,0.000005096856,3.156349e-7,0.00007508745,0.000001580869,0.9946759,0.0004467021],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005250635,0.9946616,0.00000399578,0.00004867424,0.001036693,0.002938642,0.0003793942,0.00002148542,0.0008569724],"genre_scores_gemma":[0.000009057137,0.9871024,0.00004327342,0.00004391329,0.001445836,0.008218283,0.0008560992,0.00006982192,0.00221132],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9925607,"threshold_uncertainty_score":0.9997767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049702673","doi":"10.1016/j.ctrv.2020.102086","title":"Comparison of treatment-related adverse events of different Cyclin-dependent kinase 4/6 inhibitors in metastatic breast cancer: A network meta-analysis","year":2020,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Tolerability; Metastatic breast cancer; Internal medicine; Oncology; Adverse effect; Neutropenia; Discontinuation; Breast cancer; Hazard ratio; Pharmacology; Cancer; Chemotherapy; Estrogen receptor; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1381587461601385,"gpt":0.405004672436912,"spread":0.2668459262767735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001600175,0.0007456171,0.006243234,0.0002349993,0.00004555761,0.000003444625,0.0001687646,0.00009077136,0.00170309],"category_scores_gemma":[0.00001518822,0.0004596861,0.002652629,0.001521859,0.0001110025,0.0001092866,0.00004509998,0.0001582756,0.00001299726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001706954,"about_ca_system_score_gemma":0.0002749288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002328117,"about_ca_topic_score_gemma":0.001847163,"domain_scores_codex":[0.995777,0.0004195295,0.002153955,0.0007610099,0.0004032224,0.000485275],"domain_scores_gemma":[0.9972579,0.0001091586,0.001498679,0.0006739383,0.0001123966,0.0003479549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001839936,0.00350981,0.5756865,0.0009207398,0.206137,0.00005110854,0.003476573,0.0401513,0.001612142,0.00002540413,0.00005960133,0.1665299],"study_design_scores_gemma":[0.02328795,0.004351235,0.06173586,0.001160334,0.8769237,0.00001910753,0.0007676081,0.003155827,0.01324862,0.0001040396,0.0140893,0.001156425],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4316022,0.5591402,0.000210654,0.00234144,0.0002420428,0.005309591,0.0009912589,0.00006739979,0.00009516309],"genre_scores_gemma":[0.957544,0.03928404,0.000516298,0.0001774946,0.0001043726,0.00195728,0.0001377866,0.00005629367,0.0002224932],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6707867,"threshold_uncertainty_score":0.9997855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2157880942","doi":"10.1016/j.ctrv.2007.04.003","title":"Single-agent interleukin-2 in the treatment of metastatic melanoma: A systematic review","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":90,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Ottawa Hospital; Princess Margaret Cancer Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Randomized controlled trial; Oncology; Melanoma; Internal medicine; Surgery; Complete response; Meta-analysis; Quality of life (healthcare); Chemotherapy; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.1395188464822861,"gpt":0.3899831701198975,"spread":0.2504643236376114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001222819,0.001164073,0.009232253,0.0003482364,0.00009454245,0.00002135542,0.0007020459,0.00026732,0.0005320252],"category_scores_gemma":[0.00007926467,0.0005165637,0.002561247,0.0006949349,0.0001865953,0.00005774626,0.00002444147,0.0002226208,0.0005873335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001675728,"about_ca_system_score_gemma":0.0003205889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002739299,"about_ca_topic_score_gemma":0.0001154591,"domain_scores_codex":[0.9908607,0.004579592,0.003298155,0.0005924651,0.00008947187,0.0005796311],"domain_scores_gemma":[0.9951134,0.001145593,0.002072866,0.001598156,0.00004631108,0.00002372573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003048037,0.00118388,5.753673e-7,0.3698805,0.001776115,0.00002632643,0.0005332914,1.373136e-8,0.00000915284,0.0000114124,0.0002882503,0.62626],"study_design_scores_gemma":[0.0006318437,0.001326308,2.490611e-7,0.3687801,0.00893952,0.0001717374,0.00003561708,9.018749e-9,0.00005168159,9.463545e-7,0.6198188,0.0002431263],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007421639,0.9848198,0.000005667951,0.00004320411,0.0005552794,0.01418505,0.0001189826,0.00002115187,0.0002434518],"genre_scores_gemma":[0.000002898438,0.9855444,0.0000228721,0.0002205915,0.00002508852,0.01058684,0.0003582522,0.00006289189,0.003176164],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6260169,"threshold_uncertainty_score":0.9997286,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2065151790","doi":"10.1016/j.ctrv.2011.06.009","title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review","year":2011,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Endometrial cancer; Internal medicine; Pulmonary embolism; Gynecology; Relative risk; Cancer; Oncology; Deep vein; Placebo; Obstetrics; Thrombosis; Confidence interval; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04801220906922657,"gpt":0.3587018300418929,"spread":0.3106896209726664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005275621,0.0007443106,0.0058968,0.0001515548,0.00005389321,0.00001824495,0.0002666213,0.0004651342,0.00004987099],"category_scores_gemma":[0.00004325902,0.0004789722,0.0009465464,0.000336452,0.00008284199,0.000009173131,0.00006924673,0.0001541731,0.000004022555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006149347,"about_ca_system_score_gemma":0.0005210182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003701648,"about_ca_topic_score_gemma":0.0001425262,"domain_scores_codex":[0.9967168,0.0005204958,0.00143643,0.0007407565,0.000121063,0.0004644459],"domain_scores_gemma":[0.9976878,0.00005271868,0.001420253,0.0006223407,0.00006291734,0.0001539322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000424909,0.0001887722,0.00000245318,0.5174105,0.001311574,0.000002506179,0.00006083281,3.627771e-7,0.00003366387,0.00001081507,0.0003109839,0.480625],"study_design_scores_gemma":[0.001172632,0.0005890671,0.000006365152,0.4549372,0.007058624,0.00002893341,0.000004805854,2.322454e-7,0.00003113185,0.00001465182,0.535762,0.0003944345],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001918156,0.985947,0.000008227865,0.00001737592,0.0002918928,0.01288112,0.0006018474,0.00000819407,0.00005252162],"genre_scores_gemma":[0.00001745633,0.9697222,0.00003802938,0.0000766177,0.0002789387,0.0288588,0.0002472369,0.00008487784,0.0006758539],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5354509,"threshold_uncertainty_score":0.9997662,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072076152","doi":"10.1053/ctrv.2001.0227","title":"Integration of Chinese medicine into supportive cancer care:A modern role for an ancient tradition","year":2001,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; MEDLINE; Integrative medicine; Alternative medicine; Traditional Chinese medicine; Evidence-based medicine; Western medicine; Health care; Cancer treatment; Traditional medicine; Cancer; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.2086106833031611,"gpt":0.4909616684070676,"spread":0.2823509851039065,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002254749,0.0008006867,0.004389003,0.0002517176,0.0001204964,0.00000546373,0.0001500186,0.00005845302,0.0004249588],"category_scores_gemma":[0.00006613804,0.0004154501,0.0007942581,0.0004194776,0.0001677773,0.0001074093,0.00002357596,0.0001522937,0.000003465568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00174627,"about_ca_system_score_gemma":0.0004334264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00199792,"about_ca_topic_score_gemma":0.002209785,"domain_scores_codex":[0.9971155,0.0001727391,0.001406606,0.0007122954,0.000294118,0.0002987729],"domain_scores_gemma":[0.9978389,0.00012347,0.0010602,0.0005027847,0.0002743254,0.0002003457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006624765,0.0002467349,0.0003805875,0.01673714,0.0006493754,0.000005252602,0.004924014,6.542517e-7,0.00003675123,0.00001947461,0.0006011104,0.9763327],"study_design_scores_gemma":[0.001873174,0.00431868,0.0001466917,0.03619985,0.006865888,0.00001257884,0.0005535666,0.00002724927,0.00001789412,0.000119373,0.9495839,0.0002811186],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005253812,0.9895329,0.0004763522,0.0001124653,0.0006499876,0.007541193,0.0005397857,0.00002765065,0.0005942431],"genre_scores_gemma":[0.0004560109,0.9822633,0.0003073489,0.0001099074,0.002169387,0.01019362,0.004128472,0.00005751327,0.0003144485],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9760515,"threshold_uncertainty_score":0.9998297,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042215902","doi":"10.1016/j.ctrv.2007.11.001","title":"Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Anastrozole; Exemestane; Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase; Oncology; Internal medicine; Adjuvant therapy; Hormonal therapy; Aromatase inhibitor; Randomized controlled trial; Gynecology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02335022782110961,"gpt":0.334381716166746,"spread":0.3110314883456364,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002919735,0.001141286,0.005426073,0.0001166234,0.0001066866,0.00002255834,0.0003444562,0.0005402476,0.00002142489],"category_scores_gemma":[0.00003940676,0.0006772893,0.001928279,0.0003845898,0.00007481297,0.000008519763,0.00005159884,0.0002170171,0.00006067415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007129455,"about_ca_system_score_gemma":0.0006878252,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001279295,"about_ca_topic_score_gemma":0.00002066573,"domain_scores_codex":[0.9959434,0.0007286676,0.001607332,0.00101646,0.0001629265,0.0005412183],"domain_scores_gemma":[0.997575,0.00006184311,0.001190956,0.000888329,0.00007795812,0.0002058421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005575328,0.000256553,0.000002731621,0.3402869,0.0009848045,0.00001730171,0.00002068649,2.229227e-7,0.00005953146,0.000001024951,0.02147236,0.6368421],"study_design_scores_gemma":[0.0007382531,0.0004601463,5.480601e-7,0.3749771,0.001759414,0.0001283322,0.000001493567,2.363486e-7,0.000079332,2.738795e-7,0.6213967,0.0004581874],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001660391,0.9766108,0.000002287889,0.00008163425,0.0002777273,0.02063359,0.002325722,0.00001885558,0.00003275781],"genre_scores_gemma":[0.000001191826,0.9573079,0.00005268496,0.0002521304,0.0004369162,0.03796838,0.00346755,0.0001311489,0.0003821347],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6363839,"threshold_uncertainty_score":0.9995678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064815063","doi":"10.1016/j.ctrv.2013.11.001","title":"Exercise training for people following lung resection for non-small cell lung cancer – A Cochrane systematic review","year":2013,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Physical therapy; Lung cancer; Confidence interval; Randomized controlled trial; Meta-analysis; Quality of life (healthcare); MEDLINE; Vital capacity; Strictly standardized mean difference; Lung; Internal medicine; Lung function; Diffusing capacity","retraction":null,"screen_n_in":null,"score":{"opus":0.080934093989471,"gpt":0.4138930445958479,"spread":0.3329589506063769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008919153,0.00179372,0.01578628,0.0002675933,0.0003312269,0.0001125594,0.0003357949,0.0004407876,0.0002373092],"category_scores_gemma":[0.000134503,0.00109515,0.00634412,0.0006505477,0.00002520253,0.0001526426,0.00004609038,0.0002534652,0.00004788997],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00727711,"about_ca_system_score_gemma":0.001820047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005544832,"about_ca_topic_score_gemma":0.0005293976,"domain_scores_codex":[0.9937282,0.0002553553,0.002906155,0.001638661,0.0004069646,0.001064679],"domain_scores_gemma":[0.9947835,0.0006808208,0.002225751,0.001542808,0.0002783527,0.0004888019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00002380312,0.000256571,0.00002051386,0.7000722,0.002240146,0.000008667989,0.0002472187,4.444128e-7,3.250518e-7,0.000002019406,0.01454405,0.2825841],"study_design_scores_gemma":[0.00191933,0.0004320654,5.090279e-7,0.5253038,0.1056389,0.00001199947,0.0000160489,0.00003803319,0.000006825104,8.67032e-7,0.3661503,0.0004813528],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003669898,0.8875546,0.0001436488,0.0002284684,0.001367496,0.1099903,0.0004575912,0.00008909132,0.0001650423],"genre_scores_gemma":[0.000001661193,0.6418122,0.0007800177,0.0002037152,0.000556356,0.3519041,0.0008418657,0.0002329089,0.003667146],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3516062,"threshold_uncertainty_score":0.9994808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100891604","doi":"10.1016/j.ctrv.2008.03.013","title":"Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Kingston General Hospital","funders":"","keywords":"Medicine; Trastuzumab; Oncology; Breast cancer; Internal medicine; Adjuvant; Cochrane Library; Adjuvant therapy; Randomized controlled trial; Clinical trial; Neoadjuvant therapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1158077524621631,"gpt":0.432500353013039,"spread":0.3166926005508759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009204405,0.002295403,0.01897203,0.0005496428,0.0001871878,0.00009243819,0.0007872889,0.0004667498,0.001754147],"category_scores_gemma":[0.00007326105,0.001234296,0.001443073,0.002116147,0.0002651261,0.0002051381,0.00009505624,0.001144454,0.0002719463],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0178024,"about_ca_system_score_gemma":0.006495841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001328348,"about_ca_topic_score_gemma":0.0002483493,"domain_scores_codex":[0.989544,0.001764927,0.003611768,0.001979695,0.001318223,0.001781429],"domain_scores_gemma":[0.9939998,0.0002647026,0.002019893,0.002652076,0.0002462655,0.0008172964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00009318912,0.0003390054,0.0000271661,0.4710169,0.0007439572,0.0003763431,0.0002333798,3.177537e-7,4.215894e-7,4.030152e-7,0.001726512,0.5254425],"study_design_scores_gemma":[0.001486905,0.0006976659,0.00001289613,0.5082056,0.001984422,0.001165383,0.00001704479,8.586047e-7,6.492065e-7,4.457862e-7,0.4858657,0.00056238],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000158864,0.966803,0.000002131629,0.0003693683,0.0002252518,0.03129635,0.0005733471,0.00011701,0.0005976166],"genre_scores_gemma":[0.000004144998,0.912342,0.00008487021,0.0009672436,0.0004814877,0.08421262,0.0001338148,0.0003790786,0.001394772],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5248801,"threshold_uncertainty_score":0.9991584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149388503","doi":"10.1016/j.ctrv.2008.02.003","title":"A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Sudbury Regional Hospital; McMaster University Medical Centre; Princess Margaret Cancer Centre; Queen's University; McMaster University; Cancer Care Ontario; St. Michael's Hospital","funders":"Cancer Care Ontario; Canadian Institutes of Health Research; American Society of Hematology","keywords":"Thalidomide; Medicine; Multiple myeloma; Internal medicine; Meta-analysis; Relative risk; Randomized controlled trial; Transplantation; Surgery; Oncology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1545901539710433,"gpt":0.3973100904790381,"spread":0.2427199365079948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000367654,0.001383544,0.02479163,0.0005155231,0.0001180253,0.00002323552,0.000219107,0.0002102766,0.0002103788],"category_scores_gemma":[0.0003870591,0.000611715,0.007392016,0.00132682,0.0001363868,0.00008198608,0.00004974752,0.0001467733,0.00002567469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008000543,"about_ca_system_score_gemma":0.0005751227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002688103,"about_ca_topic_score_gemma":0.0001252207,"domain_scores_codex":[0.9942744,0.0008228821,0.002581314,0.001111698,0.0005972852,0.0006123951],"domain_scores_gemma":[0.9941714,0.0008312554,0.002422276,0.001621671,0.0004689546,0.0004844665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00007013822,0.0004775497,0.0004728824,0.634343,0.2659427,0.00002329253,0.00002078232,2.867212e-8,8.164438e-9,6.238204e-7,0.0001189192,0.09853008],"study_design_scores_gemma":[0.002098678,0.0008456973,0.00002206192,0.2812802,0.5507438,0.0000275447,7.923516e-7,0.00000151242,8.452549e-7,1.935678e-7,0.1647234,0.0002551725],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006221063,0.9516119,0.00002106667,0.00002458128,0.00001845164,0.04682463,0.001405503,0.00003270657,0.00005487489],"genre_scores_gemma":[0.000005132323,0.9491001,0.001189706,0.0000773398,0.00003131807,0.04515829,0.003156599,0.0001116928,0.001169842],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3530627,"threshold_uncertainty_score":0.9998915,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015277770","doi":"10.1016/j.ctrv.2008.01.005","title":"Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Mount Sinai Hospital; Cancer Care Ontario; Ottawa Hospital","funders":"Canadian Medical Association; Cancer Care Ontario; National Center for Theoretical Sciences","keywords":"Ifosfamide; Medicine; Dacarbazine; Regimen; Soft tissue sarcoma; Doxorubicin; Chemotherapy; Oncology; Sarcoma; Internal medicine; Randomized controlled trial; Adverse effect; Surgery; Urology; Pathology; Etoposide","retraction":null,"screen_n_in":null,"score":{"opus":0.203705741555171,"gpt":0.4318251048772004,"spread":0.2281193633220295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002027674,0.001036479,0.01431276,0.001001165,0.00004566383,0.00001166392,0.0001822135,0.0002742014,0.00131822],"category_scores_gemma":[0.0000253342,0.0006083153,0.006995864,0.002158137,0.00007637328,0.00005429869,0.00001689413,0.0001657571,0.00005803936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001786813,"about_ca_system_score_gemma":0.0005277062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004551376,"about_ca_topic_score_gemma":0.0002587198,"domain_scores_codex":[0.9959148,0.0004362038,0.00198401,0.0009081773,0.0003855306,0.0003713437],"domain_scores_gemma":[0.9967373,0.0003680483,0.001372886,0.001256674,0.0001005474,0.0001645586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002401858,0.002438735,0.000779073,0.003884887,0.1008323,0.00008976326,0.00004062688,0.000008994755,3.81151e-7,0.000009012784,0.0002265183,0.8916656],"study_design_scores_gemma":[0.001730347,0.0003197852,0.0002610176,0.002103488,0.3663395,0.000008046378,0.000001172438,0.000006545016,0.00002918353,0.000001985795,0.6289635,0.000235377],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004326991,0.9930199,0.0000154872,0.0002386988,0.00006934855,0.006128703,0.0001963165,0.0000317919,0.0002565036],"genre_scores_gemma":[0.00006951697,0.9866253,0.0006702431,0.0002577131,0.00003549958,0.01049932,0.001276069,0.00008543658,0.0004808768],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8914303,"threshold_uncertainty_score":0.9996368,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3093855610","doi":"10.1016/j.ctrv.2020.102115","title":"Sarcomas: Immune biomarker expression and checkpoint inhibitor trials","year":2020,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Medicine; Biomarker; Immune checkpoint; Cancer research; Immune system; Immunotherapy; Oncology; Immunology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.2328339199402374,"gpt":0.4421817539225703,"spread":0.2093478339823328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006359332,0.00129847,0.01100581,0.0001943516,0.0001169308,0.00007066014,0.0001340266,0.000372158,0.0007268295],"category_scores_gemma":[0.0002254972,0.0006646173,0.002982296,0.0003812231,0.00008467688,0.00007059884,0.0001226891,0.0002370817,0.0003423325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0012577,"about_ca_system_score_gemma":0.0004814499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008668772,"about_ca_topic_score_gemma":0.000006001538,"domain_scores_codex":[0.9946252,0.0009166361,0.002597755,0.001146395,0.0002768878,0.0004371325],"domain_scores_gemma":[0.9966326,0.0004358273,0.001453622,0.0009291522,0.00004224774,0.0005065158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005072356,0.0005765798,0.00007702658,0.01617238,0.001269795,0.0002638753,0.00005492862,2.186952e-9,0.00002974335,0.000004685982,0.003653058,0.9778472],"study_design_scores_gemma":[0.002639951,0.0004043794,0.00004495272,0.07745669,0.01383378,0.0001421428,0.000006580707,4.235836e-7,0.0002068968,0.000003835898,0.9048234,0.0004369697],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000009983638,0.9889723,0.000002493352,0.0005174651,0.0004377024,0.009293437,0.0002140731,0.00008386118,0.0004686507],"genre_scores_gemma":[0.00000582104,0.986515,0.0005867916,0.0001421331,0.000776374,0.01083661,0.0005235596,0.0001332667,0.0004804198],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9774103,"threshold_uncertainty_score":0.9999767,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2158878352","doi":"10.1016/j.ctrv.2007.10.002","title":"New research findings on zoledronic acid: Survival, pain, and anti-tumour effects","year":2007,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Bone health and treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Oncology; Prostate cancer; Internal medicine; Renal cell carcinoma; Incidence (geometry); Bone pain; Kidney cancer; Osteonecrosis of the jaw; Cancer; Osteoporosis","retraction":null,"screen_n_in":null,"score":{"opus":0.2530439676291371,"gpt":0.5097682949917159,"spread":0.2567243273625788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002307678,0.001111744,0.005364616,0.0005682078,0.0002815166,0.00005582727,0.0001740149,0.0005249727,0.0002228553],"category_scores_gemma":[0.0002285077,0.0006631828,0.000822352,0.0008865735,0.0000951489,0.00005790282,0.0000617475,0.0008454933,0.0009772085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003033112,"about_ca_system_score_gemma":0.001996305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001422004,"about_ca_topic_score_gemma":0.0002412817,"domain_scores_codex":[0.9944763,0.001282395,0.001152229,0.001229731,0.0006100907,0.001249209],"domain_scores_gemma":[0.9964456,0.0009412442,0.0003693489,0.0009865252,0.00008255759,0.001174756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004060773,0.0002967236,0.0005040085,0.04584736,0.0004476924,0.0002701938,0.00003537927,6.036277e-9,5.062142e-7,0.0000263709,0.01118395,0.9413472],"study_design_scores_gemma":[0.002203104,0.002404479,0.0002314982,0.07854816,0.00270949,0.00006143081,0.00000336888,1.869072e-7,0.00001155908,0.000006463218,0.9134672,0.0003530935],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005451343,0.9878418,0.000006234744,0.0002305962,0.0005135892,0.009632,0.00003329212,0.00007005091,0.001617933],"genre_scores_gemma":[0.00001467509,0.9894829,0.0002176226,0.0003592232,0.0005387653,0.002260586,0.0002565905,0.000152179,0.0067175],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9409941,"threshold_uncertainty_score":0.9998006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079118647","doi":"10.1016/j.ctrv.2007.10.003","title":"Biochemotherapy for the treatment of metastatic malignant melanoma: A systematic review","year":2008,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Ottawa Hospital; Cancer Care Ontario; Sunnybrook Health Science Centre; Windsor Regional Hospital","funders":"Cancer Care Ontario","keywords":"Medicine; Hazard ratio; Internal medicine; Oncology; Chemotherapy; Confidence interval; Randomized controlled trial; Melanoma; Meta-analysis; Incidence (geometry); Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1130828280431975,"gpt":0.3923611898854493,"spread":0.2792783618422517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002321113,0.0009879742,0.009233364,0.0001663947,0.000123652,0.00001525096,0.0002113112,0.0001029204,0.0002324189],"category_scores_gemma":[0.0000454429,0.000407245,0.00400979,0.0004376814,0.00007950696,0.0000187992,0.00001250688,0.00006425226,0.00009791035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001542796,"about_ca_system_score_gemma":0.0003965253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008712952,"about_ca_topic_score_gemma":0.00002676096,"domain_scores_codex":[0.9962761,0.0003359491,0.002142511,0.0006283168,0.0002606137,0.0003565355],"domain_scores_gemma":[0.9960857,0.0004118353,0.001722863,0.001543857,0.00009065024,0.0001450832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001271579,0.0003887723,1.229935e-7,0.4977924,0.002959103,0.00002786582,0.00004304653,3.582383e-8,1.742835e-7,0.000007814398,0.001922052,0.4968459],"study_design_scores_gemma":[0.0007155738,0.001520948,3.649443e-8,0.342255,0.04167508,0.0005033266,0.000006578976,0.000001948679,0.000006081696,7.324264e-7,0.613131,0.0001836406],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.989323e-7,0.9505171,0.00009474641,0.0001963921,0.0003414812,0.04849653,0.0001633184,0.00004091236,0.0001492877],"genre_scores_gemma":[1.215465e-7,0.9419686,0.0002995642,0.0003133492,0.0001808167,0.04817979,0.0001579795,0.0001002037,0.008799626],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.611209,"threshold_uncertainty_score":0.9998379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}